In clinical trials, single doses up to 40 mg and multiple doses of up to 20 mg for ten days were evaluated, but no dose-limiting toxicity was observed. Adverse events were similar to those with lower doses, including nausea, vomiting, recurrent infections, hypersensitivity reactions, and myelosuppression. In case of overdose, patients should be monitored for signs and symptoms of adverse reactions and seek medical attention accordingly.